BPC-157 may be less appropriate for those with a history of cancer or active malignancy, individuals uncomfortable with the investigational nature of peptide therapy, people unable to commit to consistent daily administration for 4-8 weeks, those seeking instant results rather than gradual healing, and anyone who cannot source pharmaceutical-grade products from reputable suppliers
Methods: We used data from the MR CLEAN LATE trial
This is typically the responsibility of the healthcare professional
Medical-grade therapeutic peptides, like those we utilize through our partnership with PureFusion Peptides, are specifically formulated to target soft tissue repair, joint regeneration, immune modulation, and cellular recovery, depending on the patients unique condition
These studies cannot be compared directly head to head, due to differences in study design and timepoints at which weight was measured
Shaking the vial vigorously Creates foam and degrades the peptide